Free Trial

Renaissance Technologies LLC Acquires 179,568 Shares of Seer, Inc. (NASDAQ:SEER)

Seer logo with Medical background

Renaissance Technologies LLC raised its position in Seer, Inc. (NASDAQ:SEER - Free Report) by 27.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 843,700 shares of the company's stock after purchasing an additional 179,568 shares during the quarter. Renaissance Technologies LLC owned approximately 1.43% of Seer worth $1,949,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Corient Private Wealth LLC boosted its position in Seer by 66.0% in the 4th quarter. Corient Private Wealth LLC now owns 33,200 shares of the company's stock valued at $77,000 after buying an additional 13,200 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of Seer in the 4th quarter valued at $36,000. Barclays PLC boosted its position in shares of Seer by 34.1% in the 3rd quarter. Barclays PLC now owns 64,426 shares of the company's stock worth $127,000 after purchasing an additional 16,382 shares during the last quarter. Geode Capital Management LLC lifted its stake in Seer by 5.9% in the third quarter. Geode Capital Management LLC now owns 446,329 shares of the company's stock valued at $879,000 after buying an additional 25,002 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in Seer by 67.5% in the third quarter. JPMorgan Chase & Co. now owns 175,354 shares of the company's stock valued at $345,000 after buying an additional 70,671 shares during the period. 75.20% of the stock is owned by institutional investors and hedge funds.

Seer Trading Up 0.3 %

Shares of NASDAQ:SEER traded up $0.01 during mid-day trading on Thursday, reaching $2.00. The stock had a trading volume of 35,057 shares, compared to its average volume of 337,621. The firm has a market cap of $119.27 million, a PE ratio of -1.53 and a beta of 1.61. The firm has a 50 day simple moving average of $1.95 and a two-hundred day simple moving average of $2.16. Seer, Inc. has a twelve month low of $1.56 and a twelve month high of $2.63.

About Seer

(Free Report)

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

Read More

Institutional Ownership by Quarter for Seer (NASDAQ:SEER)

Should You Invest $1,000 in Seer Right Now?

Before you consider Seer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.

While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines